Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C11H17NO4.ClH |
| Molecular Weight | 263.718 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CNCC(O)C1=CC(OC)=C(O)C(OC)=C1
InChI
InChIKey=JERDKEKGVRFMRD-UHFFFAOYSA-N
InChI=1S/C11H17NO4.ClH/c1-12-6-8(13)7-4-9(15-2)11(14)10(5-7)16-3;/h4-5,8,12-14H,6H2,1-3H3;1H
| Molecular Formula | C11H17NO4 |
| Molecular Weight | 227.257 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Dimetofrine is a selective agonist of post-synaptic a1-adrenergic receptors. The drug was investigated as a cardiostimulant to treat orthostatic hypotension. Clinical investigation showed that dimetofrine relieves asthenia, paleness, drowsiness, fatigue, headache and other symptoms associated with hypotension. It was observed, that in acidic conditions similar to conditions in the stomach, dimetofrine is able to react with nitrites with the formation of highly mutagenic compound 2,6-dimethoxy-1,4-benzoquinone (DMBQ).
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:24:33 GMT 2025
by
admin
on
Mon Mar 31 22:24:33 GMT 2025
|
| Record UNII |
AUO1AP3DJR
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
245-212-6
Created by
admin on Mon Mar 31 22:24:33 GMT 2025 , Edited by admin on Mon Mar 31 22:24:33 GMT 2025
|
PRIMARY | |||
|
22775-12-8
Created by
admin on Mon Mar 31 22:24:33 GMT 2025 , Edited by admin on Mon Mar 31 22:24:33 GMT 2025
|
PRIMARY | |||
|
100000159405
Created by
admin on Mon Mar 31 22:24:33 GMT 2025 , Edited by admin on Mon Mar 31 22:24:33 GMT 2025
|
PRIMARY | |||
|
31512
Created by
admin on Mon Mar 31 22:24:33 GMT 2025 , Edited by admin on Mon Mar 31 22:24:33 GMT 2025
|
PRIMARY | |||
|
SUB169382
Created by
admin on Mon Mar 31 22:24:33 GMT 2025 , Edited by admin on Mon Mar 31 22:24:33 GMT 2025
|
PRIMARY | |||
|
m1120
Created by
admin on Mon Mar 31 22:24:33 GMT 2025 , Edited by admin on Mon Mar 31 22:24:33 GMT 2025
|
PRIMARY | Merck Index | ||
|
AUO1AP3DJR
Created by
admin on Mon Mar 31 22:24:33 GMT 2025 , Edited by admin on Mon Mar 31 22:24:33 GMT 2025
|
PRIMARY | |||
|
DTXSID70945454
Created by
admin on Mon Mar 31 22:24:33 GMT 2025 , Edited by admin on Mon Mar 31 22:24:33 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |